What is the appropriate dose for spironolactone as a fourth‐line agent in treating resistant hypertension?. Issue 6 (June 2017)

Record Type:
Journal Article
Title:
What is the appropriate dose for spironolactone as a fourth‐line agent in treating resistant hypertension?. Issue 6 (June 2017)
Main Title:
What is the appropriate dose for spironolactone as a fourth‐line agent in treating resistant hypertension?
Authors:
Moonesinghe, Kushan
Talati, Khyati
Abstract:
Abstract : Bottom line : In patients with resistant hypertension, 48% to 73% can be controlled by adding 25 to 50 mg spironolactone. Increasing to 100 mg may not have any more effect (SOR: C, RCT and cohort study with disease‐oriented outcomes).
Is Part Of:
Evidence-based practice. Volume 20:Issue 6(2017)
Journal:
Evidence-based practice
Issue:
Volume 20:Issue 6(2017)
Issue Display:
Volume 20, Issue 6 (2017)
Year:
2017
Volume:
20
Issue:
6
Issue Sort Value:
2017-0020-0006-0000
Page Start:
Page End:
Publication Date:
2017-06
Journal URLs:
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1097/01.EBP.0000541741.82702.3c ↗
Languages:
English
ISSNs:
1095-4120
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3831.037550
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
17010.xml